产品标题 产品货号 产品规格 厂家
TNFRSF4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4112531 kitORIGENE TECHNOLOGIES
TNFRSF25 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4121751 kitORIGENE TECHNOLOGIES
TNFRSF8 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4198191 kitORIGENE TECHNOLOGIES
TNFRSF18 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4199971 kitORIGENE TECHNOLOGIES
Tnfrsf14 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5179791 kitORIGENE TECHNOLOGIES
Tnfrsf18 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5179811 kitORIGENE TECHNOLOGIES
Tnfrsf19 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5179821 kitORIGENE TECHNOLOGIES
Tnfrsf21 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5179851 kitORIGENE TECHNOLOGIES
Tnfrsf22 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5179861 kitORIGENE TECHNOLOGIES
Tnfrsf23 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5179871 kitORIGENE TECHNOLOGIES
Tnfrsf25 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5179881 kitORIGENE TECHNOLOGIES
Tnfrsf26 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5179891 kitORIGENE TECHNOLOGIES
Human Ovary-Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCS700975n/aORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7004025x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7004035x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7022625x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7033245x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7033255x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7066135x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS7108655x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8016725x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8044595x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8058525x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8063505x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8064845x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8064855x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8064865x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8069825x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8069835x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8069845x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8073685x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8073695x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8078785x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8085735x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8088035x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8088045x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCS8103265x5umORIGENE TECHNOLOGIES
C11orf46 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30841310 ugORIGENE TECHNOLOGIES
C11orf48 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30078210 ugORIGENE TECHNOLOGIES
C11orf49 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30143510 ugORIGENE TECHNOLOGIES
C11orf53 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30814210 ugORIGENE TECHNOLOGIES
C11orf58 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH32696910 ugORIGENE TECHNOLOGIES
C11orf58 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30332910 ugORIGENE TECHNOLOGIES
C11orf61 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH32380510 ugORIGENE TECHNOLOGIES
C11orf67 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30103310 ugORIGENE TECHNOLOGIES
C11orf68 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30456010 ugORIGENE TECHNOLOGIES
C11orf73 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30086610 ugORIGENE TECHNOLOGIES
C11orf74 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30841710 ugORIGENE TECHNOLOGIES
C11orf75 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30646610 ugORIGENE TECHNOLOGIES
C11orf84 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30818110 ugORIGENE TECHNOLOGIES
 |< < 2305 2306 2307 2308 2309 2310 2311 2312 2313 > >| 第 2305/6274 页